HealthDay - THURSDAY, April 24 (HealthDay News) -- be in the driver's seat on switching to
a second-line series of drugs for HIV/AIDS clients who are failing the
first-line regimen are often made on the basis of sophisticated and
expensive lab tests.

More: - From the site